India Anesthesia & Respiratory Devices Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Product Type, By End User, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
India · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$587.1 MnPlaceholder estimate
Estimate 2025$660.5 Mn1.9% of the global market
Projected 2034$1.91 Bn 188.7%Adds $1.25 Bn over 9 forecast years
CAGR 2025–203412.5%Faster than 57% of 173 Medical Devices markets here
6 in IndiaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in India. Retrieved 9 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The India Anesthesia & Respiratory Devices Market Executive Summary
Anesthesia breathing systems function to deliver inhaled gases to patients. These most often include a mixture of fresh gas (oxygen, air) and anesthetic gases, both volatile agents (e.g., isoflurane) and non-volatile agents (nitrous oxide).
The Anesthesia and Respiratory Devices Market is experiencing significant growth, driven by the rising prevalence of respiratory diseases like COPD and sleep apnea, an aging population, and the increasing number of surgeries requiring anesthesia. Key segments include anesthesia machines, ventilators, and CPAP devices, with major players like Medtronic and GE Healthcare leading the market. North America dominates, while the Asia-Pacific region is expected to grow rapidly. Challenges include high device costs and stringent regulations, but advancements in portable and AI-integrated devices are expected to fuel future growth.
India Anesthesia & Respiratory Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
India Anesthesia & Respiratory Devices Market Dynamics
Market Growth Drivers
Chronic respiratory diseases, including COPD, asthma, and sleep apnea affect about 545 Mn people, which indicate an increasing need for respiratory care devices and solutions. Furthermore, there has been a global increase in the number of surgeries—approximately 230 Mn major surgeries annually—further stimulating the development of enhanced anesthesia devices. The development of new technologies and integration of intelligence and smart features not only increases the effectiveness of these devices but also increases their applications in clinical settings.
Opportunity
The availability of opportunities in Asia-Pacific, Latin America, and the Middle East & Africa due to better healthcare and gradually growing incomes are expected to be lucrative for anesthesia and respiratory devices. Other drivers include aging population that increases the need for specialized medical devices while the population of children is also on the rise, making the need for pediatric devices higher.
Market Restraints
Expensive equipment, maintenance costs, and the financial burden of training personnel are key barriers to adoption, especially in developing regions. Severe market competition results in increased pressure to reduce prices, which affects the revenue and investment in research. Fluctuations in the economic cycle and available funds limit investment in new technologies, while lack of awareness in some new markets may hinder the use of superior devices.
Competitive Landscape for Anesthesia & Respiratory Devices Market in India
April 2024, Johnson & Johnson launched two new devices in EMEA. The Ethizia haemostatic sealing patch and the Cereglide aspiration catheter were launched last week by two J&J medtech companies.
August 2025, Mindray Introduced Innovative Upgrades to A Series Anesthesia Systems for Enhanced Patient Safety and Efficiency. Mindray has unveiled exciting upgrades to its A7 and A5 anesthesia systems under the A Series Anesthesia. The brand-new enhancements incorporate innovative technologies that empower anesthesiologists to deliver precise anesthesia, leading to greater patient safety and efficiency throughout the perioperative period.
April 2022, GE Healthcare Received FDA Approval of First-Ever Software to Help Automate Anesthesia Delivery and Reduce Greenhouse Gas Emissions During Surgery.
Mergers and Acquisitions
October 2025, AirLife, a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care formerly known as SunMed, announced the completion of its acquisition of Avanos Medical, Inc.’s respiratory health business, including the BALLARD, MICROCUFF and endOclear product lines.
Healthcare Policies and Regulatory Landscape for Anesthesia & Respiratory Devices Market in India
Anesthesia & Respiratory Devices in India: rules, payment and research
Since October 2023, every medical device sold in India needs a licence under the Medical Devices Rules, 2017, from the Central Drugs Standard Control Organisation (CDSCO) or, for some lower-risk devices made in India, a state authority.[1] Ayushman Bharat PM-JAY gives eligible families hospital cover of up to ₹5 lakh a year.[2] ClinicalTrials.gov lists 6 studies on Anesthesia & Respiratory Devices that are recruiting, active or about to start in India.[3]
[3]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in India. Retrieved 9 Nov 2026.
Policy changes and Reimbursement scenario
There is high stringency in the regulatory environment of anesthesia and respiratory related devices which can include high approval hurdles and frequently changing standards that can slow down the market entry and entail steep expenses. They have favourable reimbursement policies which help in boosting up the market in the developed country while in the emerging country matters may be slightly difficult due to the absence of well-formulated reimbursement policies. Further, reimbursement pressures are compounded with possible future reductions in coverage and reduced reimbursement for devices and services, newly introduced principles of value-based purchasing and need for better reporting of cost-effectiveness and positive patient outcomes in order to gain reimbursement and adoption.
8.2 Government Initiatives / Intervention programs
The anesthesia and respiratory devices market is segmented into various categories that help in understanding its dynamics and addressing specific healthcare needs. Here’s a detailed overview of the market segmentation:
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: FDA 510(k) and PMA databases, 510(k) clearances and PMA approvals since 2015 for devices whose name has this market's words. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Anesthesia & Respiratory Devices right now, from free public sources.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Anesthesia & Respiratory Devices in context
India compared
Health spending per person: 85 US$ per person (2023). World: 1,317 US$ per person (2023). 10th highest of the 15 countries we cover in APAC.[1]
Doctors: 0.72 per 1,000 people (2020). World: 1.86 per 1,000 people (2022). 11th highest of the 15 countries we cover in APAC.[2]
People aged 65 and over: 7.4% of people (2025). World: 10.4% of people (2025). 11th highest of the 16 countries we cover in APAC.[3]
[1]World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
How big is the Anesthesia & Respiratory Devices market in India?
Placeholder estimate: about $660.5 Mn in 2025, rising to about $1.91 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Anesthesia & Respiratory Devices market in India growing?
Placeholder estimate: about 12.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Anesthesia & Respiratory Devices market report cover?
The report splits the market by product type (Anesthesia Devices, Respiratory Devices) and end user (Hospitals, Clinics, Homecare Settings, Ambulatory Service Centres).
Who are the key players in the Anesthesia & Respiratory Devices market?
Key players include GE Healthcare, Medtronic, Teleflex Inc, Koninklijke Philips N.V. and Drägerwerk AG & Co. KGaA.
What is driving the Anesthesia & Respiratory Devices market?
Chronic respiratory diseases, including COPD, asthma, and sleep apnea affect about 545 Mn people, which indicate an increasing need for respiratory care devices and solutions.
Who regulates Anesthesia & Respiratory Devices in India?
Since October 2023, every medical device sold in India needs a licence under the Medical Devices Rules, 2017, from the Central Drugs Standard Control Organisation (CDSCO) or, for some lower-risk devices made in India, a state authority. Source: Central Drugs Standard Control Organisation. Checked 14 Nov 2026.
How is healthcare paid for in India?
Ayushman Bharat PM-JAY gives eligible families hospital cover of up to ₹5 lakh a year. Source: National Health Authority (PM-JAY). Checked 14 Nov 2026.
How many clinical trials on Anesthesia & Respiratory Devices are running in India?
6 studies are recruiting, active or about to start in India, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in India. Retrieved 9 Nov 2026.
How much research is published on Anesthesia & Respiratory Devices?
PubMed lists 7,161 papers on Anesthesia & Respiratory Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.